FIELD: biotechnology.
SUBSTANCE: lentiviral vectors designed to carry the A (H1N1) and A (H3N2) influenza virus protein gene cassette and type B coding influenza virus protein sequences for transduction of mammalian cells. Method describes how to obtain these vectors and kits for their production.
EFFECT: obtained lentiviral vectors are used further to create cell-producers of virus-like particles (HPV) of the influenza virus.
15 cl, 6 tbl, 6 ex, 34 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING A POLYVALENT INFLUENZA VACCINE | 2018 |
|
RU2701953C1 |
CONCENTRATE OF INFLUENZA VACCINE AND METHOD FOR ITS PREPARATION | 2018 |
|
RU2706544C1 |
FLU VIRUS PROTEINS PRODUCER MDCK CELL (OPTIONS) | 2018 |
|
RU2681482C1 |
MULTIVALENT INFLUENZA VACCINE | 2018 |
|
RU2706191C1 |
INFLUENZA VIRUS THE VIRUS-LIKE PARTICLE AND ITS OBTAINING METHOD | 2018 |
|
RU2681439C1 |
METHOD OF CONTROLLING PRODUCTION OF A VACCINE AGAINST INFLUENZA | 2018 |
|
RU2701959C1 |
CASSETTE INTENDED FOR OBTAINING PLASMID VECTORS USED TO CREATE CELL PRODUCERS OF VIRUS-LIKE PARTICLES (VLP) OF INFLUENZA VIRUS | 2018 |
|
RU2680703C1 |
STRAIN OF BACTERIA ESCHERICHIA COLI - PRODUCER OF RECOMBINANT PROTEIN NS1 | 2021 |
|
RU2789735C1 |
HYBRID PROTEIN-BASED POLYVALENT INFLUENZA VACCINE | 2013 |
|
RU2531235C2 |
OBTAINING VIRUS-LIKE PARTICLES OF INFLUENZA VIRUS IN PLANTS | 2014 |
|
RU2742607C1 |
Authors
Dates
2019-02-22—Published
2018-02-13—Filed